逆行式喉功能障碍有效地用低剂量肉毒素治疗. 来自意大利的案例报告
Luca Pavesi1, Cecilia Balzano1, Simone Mauramati2
1Independent Researcher in Pharmaceutical Chemistry and Technology and in Nutritional Sciences, Novara, Italy.
Frontiers in neurology
|August 25, 2023
概括
逆行性喉功能障碍 (R-CPD) 是一种带有不明原因症状的疾病. 一项新的案例研究表明,使用低剂量的毒素进行了成功的无麻醉治疗,这为潜在的新疗法提供了新的治疗方法.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 胃肠病学 胃肠病学
- 神经学 神经学
背景情况:
- 逆行性喉功能障碍 (R-CPD) 是一种最近定义的疾病,其特征是无法发,胀气和排泄恐惧症等症状.
- 目前的第一线治疗包括注射肉毒素 (BT) 进入大肌,这是有效的,但需要麻醉.
- 在R-CPD中BT的最佳治疗剂量仍需确定.
研究的目的:
- 报告在意大利诊断的第一个R-CPD病例.
- 描述一种新的,无麻醉的治疗方法,用于R-CPD.
- 为了展示低剂量纳毒素注射对R-CPD的疗效.
主要方法:
- 在临床表现的基础上诊断R-CPD.
- 单侧注射10个单位的毒素进入喉肌肉.
- 无麻醉的程序. 无麻醉的程序.
主要成果:
- 成功地解决了R-CPD症状.
- 这是迄今为止用于R-CPD治疗的最低报告剂量 (10单位).
- 与无麻醉注射相关的有限的不良事件.
结论:
- 无麻醉,低剂量的毒素注射是R-CPD的可行和有效治疗方法.
- 这种方法代表了一种潜在的更安全,更容易获得的治疗选择.
- 需要进一步的研究来确定最终的剂量范围和长期结果.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
511
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
703
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
703
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
715
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
715


